Other Proposed Uses
What Is Bilberry Used for Today?
What Is the Scientific Evidence for Bilberry?
Interactions You Should Know About
- Medications to reduce blood sugar : bilberry leaf (not fruit) might amplify the effect, and you may need to reduce your dose of medication.
1 Monboisse JC, Braquet P, Randoux A, et al. Non-enzymatic degradation of acid-soluble calf skin collagen by superoxide ion: Protective effect of flavonoids. Biochem Pharmacol . 1983;32:53-58.
2 Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharmacol . 1983;32:1141-1148.
3 Gabor M. Pharmacologic effects of flavonoids on blood vessels. Angiologica . 1972;9:355-374.
4 Mian E, Curri SB, Lietti A, et al. Anthocyanosides and the walls of the microvessels: further aspects of the mechanism of action of their protective effect in syndromes due to abnormal capillary fragility [in Italian; English abstract]. Minerva Med . 1977;68:3565-3581.
5 Pulliero G, Montin S, Bettini V, et al. Ex vivo study of the inhibitory effects of Vaccinium myrtillus anthocyanosides on human platelet aggregation. Fitoterapia . 1989;60:69-75.
6 Wegmann R, Maeda K, Tronche P, et al. Effects of anthocyanosides on photoreceptors. Cytoenzymatic aspects [translated from French]. Ann Histochim . 1969;14:237-256.
7 Cluzel C, Bastide P, Wegman R, et al. Enzymatic activities in the retina and anthocyanosides extracted from Vaccinium myrtillus (lactate dehydrogenase, alpha-hydroxybutyrate dehydrogenase, 6-phosphogluonate dehydrogenase, glucose-6-phosphate dehydrogenase, alpha-glycerophosphate dehydrogenase, 5-nucleotide, and phosphoglucose isomerase) [translated from French]. Biochem Pharmacol. 1970;19:2295-2302.
8 Cignarella A, Nastasi M, Cavalli E, et al. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res. 1996;84:311-322.
9 Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Altern Med Rev. 2000;5:164-173.
10 Zadok D, Levy Y, Glovinsky Y, et al. The effect of anthocyanosides on night vision tests. Invest Ophthalmol Vis Sci. 1997;38(suppl):633.
11 Levy Y, Glovinsky Y. The effect of anthocyanosides on night vision. Eye . 1998;12:967-969.
12 Jayle GE, Aubert L. Action of anthocyan glucosides on the scotopic and mesopic vision of the normal subject [in French; English abstract]. Therapie. 1964;19:171-185.
13 Jayle GE, Aubry M, Gavini H, et al. Study concerning the action of anthocyanoside extracts of Vaccinium myrtillus on night vision [in French]. Ann Ocul (Paris) . 1965;198:556-562.
14 Bone K. Bilberry-The vision herb. MediHerb Prof Rev . 1997;59:1-4.
15 Sala D, Rolando M, Rossi PL, et al. Effect of anthocyanosides on visual performance at low illumination [in Italian; English abstract]. Minerva Oftalmol . 1979;21:283-285.
16 Gloria E, Peria A. Effect of anthocyanosides on the absolute visual threshold [in Italian; English abstract]. Ann Ottalmol Clin Ocul . 1966;92:595-607.
17 Caselli L. Clinical and electroretinographic study on activity of anthocyanosides [in Italian; English abstract]. Arch Med Intern (Parma) . 1985;37:29-35.
18 Bone K. Bilberry-The vision herb. MediHerb Prof Rev . 1997;59:1-4.
19 Bone K. Bilberry-The vision herb. MediHerb Prof Rev . 1997;59:1-4.
20 Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies [translated from German]. Klin Monatsbl Augenheilkd. 1981;178:386-389.
21 Lietti A, Cristoni A, Picci M. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimittelforschung . 1976;26:829-832.
22 Lietti A, Forni G. Studies on Vaccinium myrtillus anthocyanosides. II. Aspects of anthocyanin pharmacokinetics in the rat. Arzneimittelforschung . 1976;26:832-835.
23 Eandi M. Post marketing investigation on TegensŴ preparation with respect to side effects. Unpublished results. Cited by: Morazzoni P, Bombardelli E. Vaccinium myrtillus. Fitoterapia . 1996;67:3-29.
24 Grismondi GL. Treatment of phlebopathies caused by stasis in pregnancy [translated from Italian]. Minerva Ginecol . 1981;33:221-230.
25 Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies [translated from German]. Klin Monatsbl Augenheilkd. 1981;178:386-389.
26 Cignarella A, Nastasi M, Cavalli E, et al. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res. 1996;84:311-322.
27 Villalba G. Anthocyanosides as a new vasculotrophic agent in patients with hemorrhoids. Medicina (Mex). 1974;54:73-76.
28 Kianbakht S, Abasi B, et al. Anti-hyperglycemic effect of Vaccinium arctostaphylos in type 2 diabetic patients: a randomized controlled trial. Forsch Komplementmed. 2013;20(1):17-22.
- Reviewer: EBSCO CAM Review Board
- Review Date: 09/2014 -
- Update Date: 09/18/2014 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.